Delivery Order SPE2DB24D1205-SPE2DB25FCZTP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 mL pens with a ceiling value of $6,208.02. This firm fixed-price delivery order is a non-set-aside award and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 5 mg/0.5 mL pens valued at $3,050.32 with a completion date of August 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,640.30 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This firm fixed-price contract, which is a child order under a larger contract vehicle, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $20,902.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This contract, which carries an ultimate completion date of July 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order was competitively awarded without set-aside...
- The Defense Logistics Agency awarded a $1,143.87 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The order represents a child delivery order under a larger contract vehicle, enabling the pharmaceutical distributor to supply critical medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with a ceiling value of $1,372.93. This is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. The performance location is in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $14,455.29 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $3,647.57. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $28,029.17 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price delivery order is set to be completed by August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,827.30 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (0.5ml units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger prime Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZTPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,614.56 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This competitive, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle extending through December 2026. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with a completion date of August 21, 2025. No set-aside designation was utilized for this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company holds a comprehensive global pharmaceutical support contract enabling it to supply a broad range of medications and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order for Zepbound, a diabetes medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements within the DLA's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 8/20/25 |